Longboard Pharmaceuticals, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Longboard Pharmaceuticals, Inc. | LBPH - NASDAQ |
$14.00-$16.00 | $16.00 | $16.00 | 5 million | 3/12/2021 |
| Citigroup, Evercore ISI, Guggenheim Securities, Cantor | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-02-19 Terms Added 2021-03-08 | ||||||
Longboard Pharmaceuticals, Inc. Quote & Chart - Click for current quote - LBPH
IPO Boutique aggregates information on public companies and private companies, such as "LBPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Longboard Pharmaceuticals, Inc. (adapted from Longboard Pharmaceuticals, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "LBPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.